Stay updated on Molecularly Matched Targeted Therapies in Tumor Types Clinical Trial
Sign up to get notified when there's something new on the Molecularly Matched Targeted Therapies in Tumor Types Clinical Trial page.

Latest updates to the Molecularly Matched Targeted Therapies in Tumor Types Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the completed study is displayed, including its eligibility criteria, treatment arms, and outcome measures, instead of a forbidden-error message.SummaryDifference69%

- Check13 days agoChange DetectedThe study record no longer shows a 403 error and instead displays the standard site navigation and footer, with the study details area largely blank.SummaryDifference0.6%

- Check19 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous detailed study information with an access-denied message, effectively blocking viewing of the trial details.SummaryDifference21%

Stay in the know with updates to Molecularly Matched Targeted Therapies in Tumor Types Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Molecularly Matched Targeted Therapies in Tumor Types Clinical Trial page.